Paul Swanson

423 total citations
9 papers, 334 citations indexed

About

Paul Swanson is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Paul Swanson has authored 9 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Paul Swanson's work include Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Research Studies (2 papers). Paul Swanson is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Colorectal Cancer Treatments and Studies (3 papers) and Lung Cancer Research Studies (2 papers). Paul Swanson collaborates with scholars based in United States and United Kingdom. Paul Swanson's co-authors include Howard A. Burris, Jordan Berlin, J. Randolph Hecht, William P. Tong, Robert S. DiPaola, Kathryn L. Terry, William Kevin Kelly, Neal Rosen, Carlos Cordon‐Cardo and Marija Drobnjak and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Journal of Thoracic Oncology.

In The Last Decade

Paul Swanson

9 papers receiving 327 citations

Peers

Paul Swanson
Tao Osgood United States
Patrick Chun United States
Xuejing Aimee Wang United States
AT Skarin United States
L. Hart United States
Tao Osgood United States
Paul Swanson
Citations per year, relative to Paul Swanson Paul Swanson (= 1×) peers Tao Osgood

Countries citing papers authored by Paul Swanson

Since Specialization
Citations

This map shows the geographic impact of Paul Swanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Swanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Swanson more than expected).

Fields of papers citing papers by Paul Swanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Swanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Swanson. The network helps show where Paul Swanson may publish in the future.

Co-authorship network of co-authors of Paul Swanson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Swanson. A scholar is included among the top collaborators of Paul Swanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Swanson. Paul Swanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gerber, David E., Paul Swanson, Ariel López-Chávez, et al.. (2017). Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC. Lung Cancer. 111. 108–115. 9 indexed citations
3.
Crawford, Jeffrey, Paul Swanson, Paul Schwarzenberger, et al.. (2013). A Phase 2 Randomized Trial of Paclitaxel and Carboplatin with or without Panitumumab for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(12). 1510–1518. 18 indexed citations
4.
Hecht, J. Randolph, Edith P. Mitchell, Marcus A. Neubauer, et al.. (2010). Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer. Clinical Cancer Research. 16(7). 2205–2213. 77 indexed citations
5.
Ross, Helen J., Lowell L. Hart, Paul Swanson, et al.. (2006). A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma. Lung Cancer. 54(1). 69–77. 29 indexed citations
6.
Berlin, Jordan, M. Neubauer, Paul Swanson, et al.. (2006). Panitumumab antitumor activity in patients (pts) with metastatic colorectal cancer (mCRC) expressing ≥ 10% epidermal growth factor receptor (EGFr). Journal of Clinical Oncology. 24(18_suppl). 3548–3548. 55 indexed citations
7.
Ross, Helen J., Charles M. Rudin, Lowell L. Hart, et al.. (2004). Randomized phase II study of SGN-15 (CBR96-doxorubicin immunoconjugate) with docetaxel in patients with advanced or metastatic non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7039–7039. 9 indexed citations
8.
Morris, Michael J., William P. Tong, Carlos Cordon‐Cardo, et al.. (2002). Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer.. PubMed. 8(3). 679–83. 132 indexed citations
9.
Swanson, Paul, et al.. (1992). Identification and characterization of an α-mannosidase from Trypanosoma cruzi. Glycobiology. 2(6). 563–569. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026